Form 4: HealthStream EVP Collier Reports Stock Transactions
Insider Transaction Report
HealthStream Executive Vice President Michael Manning Collier reported the acquisition of shares from RSU vesting and subsequent sale for tax obligations.
Summary
- Michael Manning Collier, Executive Vice President of HealthStream Inc. (HSTM), reported transactions involving the company's common stock.
- On September 29, 2025, Collier acquired 1,087 shares of common stock at a price of $0, resulting from the vesting of restricted share units (RSUs).
- Concurrently, 265 shares of common stock were disposed of at a price of $29.08 per share to cover tax liabilities associated with the RSU vesting.
- Following these transactions, Collier's direct beneficial ownership of common stock stands at 50,304 shares.
- Collier also holds Restricted Share Units (RSUs) representing the contingent right to receive additional shares upon future vesting, with 2,285 and 2,176 underlying shares remaining in two separate grants.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving RSU vesting and tax-related share disposition, which is a neutral event in terms of company performance or outlook.
Positives
- The vesting of 1,087 restricted share units indicates continued service and compensation for a key executive.
- The acquisition of shares at a $0 price point reflects a non-cash compensation event, enhancing the executive's equity stake.
Negatives
- A portion of the vested shares (265 shares) was sold to cover tax liabilities, reducing the executive's direct beneficial ownership.
Future Outlook
Future share acquisitions for Michael Manning Collier are scheduled through the vesting of remaining Restricted Share Units, with specific vesting dates extending until September 18, 2028, contingent upon continued service.
Industry Context
This Form 4 filing represents a routine insider transaction, common for executives receiving equity compensation such as Restricted Share Units. Such filings provide transparency into executive stock ownership and compensation structures within the healthcare technology industry.
Stakeholder Impact
- Shareholders: Provides transparency into executive compensation and ownership, but unlikely to have a significant direct impact on share price due to the routine nature of the transaction.
- Employees: Reflects standard executive compensation practices, which may be part of broader company-wide equity incentive programs.
Next Steps
- Future vesting of Restricted Share Units on September 18, 2025 (20% of second batch), September 20, 2025 (20% of first batch), September 18, 2026 (20% of second batch), September 20, 2026 (30% of first batch), September 18, 2027 (30% of second batch), September 20, 2027 (35% of first batch), and September 18, 2028 (35% of second batch).
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | 15% of the first batch of Restricted Share Units (RSUs) vested. |
| 09/18/2025 | 15% of the second batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/20/2025 | 20% of the first batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/29/2025 | Shares acquired on vesting of restricted share units and shares withheld for payment of tax liability. |
| 09/18/2026 | 20% of the second batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/20/2026 | 30% of the first batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/18/2027 | 30% of the second batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/20/2027 | 35% of the first batch of Restricted Share Units (RSUs) is scheduled to vest. |
| 09/18/2028 | 35% of the second batch of Restricted Share Units (RSUs) is scheduled to vest. |
Recommendation
holdThis Form 4 filing details a routine insider transaction related to executive compensation (RSU vesting and tax withholding). It does not contain new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a 'buy' or 'sell' decision.
Keywords
HealthStream, HSTM, Form 4, Insider Transaction, Restricted Share Units, RSU Vesting, Executive Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.